Arbutus Says Announces Workforce Reduction Of 24% Effective Nov. 6, 2023, Primarily Affecting Research Function
Portfolio Pulse from Benzinga Newsdesk
Arbutus Biopharma Corporation has announced a workforce reduction of 24% effective from November 6, 2023. The reduction will primarily affect the company's research function.
November 07, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Arbutus Biopharma Corporation's announcement of a 24% workforce reduction, primarily affecting its research function, may impact the company's stock in the short term.
Workforce reductions often indicate financial difficulties or strategic shifts within a company. This could lead to uncertainty among investors, potentially negatively impacting the stock price. The fact that the reduction primarily affects the research function could also raise concerns about the company's future product pipeline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100